Q2 2019 Zyla Life Sciences Earnings Call
שיחת ועידה Zyla Life Sciences
Zyla Life Sciences Conference call or earnings call will be held on 13/08/2019 via an 800 number (toll-free). During the earnings conference call's session Zyla Life Sciences will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Zyla Life Sciences for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a fully integrated specialty pharmaceutical company developing, manufacturing and commercializing innovative treatments for pain and other conditions. Egalet was founded around our proprietary Guardian(TM) Technology that can be applied broadly across different classes of pharmaceutical products. Using this technology, we have two late-stage product candidates in development; ARYMO ER(TM), formerly known as Egalet-001, an abuse-deterrent ("AD"), extended-release ("ER"), oral morphine formulation, which, if approved by the U.S. Food and Drug Administration ("FDA"), could be on the market in 2016, and Egalet-002, an AD, ER, oral oxycodone formulation, which is in a Phase 3 program (our "lead product candidates"). Both lead product candidates are in development for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.קרא עוד שיחת ועידה